1-hydroxymethylmidazolam has been researched along with u 74006f in 1 studies
Studies (1-hydroxymethylmidazolam) | Trials (1-hydroxymethylmidazolam) | Recent Studies (post-2010) (1-hydroxymethylmidazolam) | Studies (u 74006f) | Trials (u 74006f) | Recent Studies (post-2010) (u 74006f) |
---|---|---|---|---|---|
163 | 46 | 49 | 362 | 49 | 11 |
Protein | Taxonomy | 1-hydroxymethylmidazolam (IC50) | u 74006f (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.718 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 1.116 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 7.898 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 2.002 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.718 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 7.406 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fleishaker, JC; Hopkins, NK; Pearson, LK; Pearson, PG; Peters, GR; Wienkers, LC | 1 |
1 trial(s) available for 1-hydroxymethylmidazolam and u 74006f
Article | Year |
---|---|
Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A.
Topics: Adolescent; Adult; Age Factors; Aged; Antioxidants; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Body Weight; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Estrogens; Female; Hormone Replacement Therapy; Humans; Metabolic Clearance Rate; Midazolam; Middle Aged; Oxidoreductases, N-Demethylating; Postmenopause; Pregnatrienes; Premenopause; Progesterone | 1999 |